• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Research & Development

Report: Pipeline of Alzheimer’s drugs ‘due for big victories’ in next 5 years

July 19, 2017 By Sarah Faulkner

There are twenty-seven Alzheimer’s drugs in late-stage clinical trials and eight candidates in Phase II programs that could launch in the next 5 years, according to an analysis presented this week at the Alzheimer’s Association International Conference. “The Alzheimer’s disease pipeline, marred by decades of failures and underinvestment, is due for big victories,” UsAgainstAlzheimer’s co-founder […]

Filed Under: Featured, Neurological, Pharmaceuticals, Research & Development Tagged With: Centers for Disease Control & Prevention

Epilepsy biomarker could aid in early detection, targeted treatment

July 19, 2017 By Sarah Faulkner

Dr. Jeffrey Loeb

Researchers from the University of Illinois at Chicago College of Medicine have identified a unique chemical biomarker associated with epileptic brain tissue, according to an article published in the journal Epilepsia. The chemical signature can be detected noninvasively and could enable physicians to precisely locate small regions of abnormal brain tissue in early-stage patients. The researchers […]

Filed Under: Diagnostics, Featured, Neurological, Research & Development Tagged With: University of Illinois at Chicago

Corium touts clinical data for transdermal delivery of Alzheimer’s drug

July 18, 2017 By Sarah Faulkner

Corium

Corium (NSDQ:CORI) touted data today from a pilot bioequivalence study, comparing its Corplex Donepezil transdermal patch to oral Aricept as delivery method for the most commonly prescribed treatment for Alzheimer’s disease. Data from the pilot study demonstrated that Corium’s transdermal patch met the criteria for bioequivalence to oral Aricept, as measured by primary pharmacokinetic endpoints […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Neurological, Pharmaceuticals, Research & Development, Wall Street Beat Tagged With: Corium

Mobile diagnostic device detects tumor cells in blood

July 17, 2017 By Sarah Faulkner

mobile diagnostic device

Researchers from the Rovira i Virgili University have developed and patented a mobile diagnostic device that can detect tumor cells in blood, according to a study published in Scientific Reports. The team reported that the device can quantify tumor cells in a blood sample in real-time, positioning it as a tool to boost the diagnosis and […]

Filed Under: Diagnostics, Featured, Oncology, Research & Development

Medtech stories we missed this week: July 14, 2017

July 14, 2017 By Danielle Kirsh

missed medtech

From Novarad touting its VR-surgical guidance system to Zynex paying off its $2.2M loan, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Stimwave announces first patient in Brazil Stimwave announced in a July 5 press release that its first patients in Brazil have received Stimwave’s wireless pain relief […]

Filed Under: Clinical Trials, Diabetes, Diagnostics, Featured, Imaging, Pain Management, Research & Development Tagged With: American Red Cross, Nemaura Medical, Novarad, Owlstone Medical, Stimwave, Tactical Medical, Zynex Inc.

MIT researchers fight drug-resistant bacteria with nanoparticles

July 13, 2017 By Sarah Faulkner

Antibiotics

Scientists from the Massachusetts Institute of Technology are using nanoparticles to tackle drug-resistant bacteria, according to a study published in Advanced Materials. Gram-negative bacteria are particularly difficult to treat, since they are protected by two cell membranes. But the team of Cambridge-based researchers reported that antimicrobial peptides inside of a silicon nanoparticle effectively reduced the number […]

Filed Under: Featured, Nanoparticles, Pharmaceuticals, Research & Development Tagged With: Massachusetts Institute of Technology

Blood test enhances early detection of pancreatic cancer

July 12, 2017 By Sarah Faulkner

pancreatic cancer

Researchers from the University of Pennsylvania have devised a biomarker panel that could enable earlier diagnosis and better treatment for patients with pancreatic cancer, according to a study published in Science Translational Medicine. Pancreatic cancer is the fourth leading cause of cancer death in the U.S., the team reported, and often patients are not diagnosed until […]

Filed Under: Diagnostics, Featured, Oncology, Research & Development Tagged With: University of Pennsylvania

Study: Nanomedicine shuts down cells that drive cancer growth in glioblastoma

July 12, 2017 By Sarah Faulkner

Brain

Researchers from Northwestern Medicine have developed lipid polymer-based nanoparticles that target key cancer drivers, called brain tumor initiating cells, in a mouse model of glioblastoma brain tumors. “BTICs are malignant brain tumor populations that underlie the therapy resistance, recurrence and unstoppable invasion commonly encountered by glioblastoma patients after the standard treatment regimen of surgical resection, […]

Filed Under: Drug-Device Combinations, Featured, Nanoparticles, Neurological, Oncology, Research & Development Tagged With: Northwestern University

Synspira’s therapy could boost antibiotics against drug-resistant bacteria in CF patients

July 12, 2017 By Sarah Faulkner

Synspira

Privately-held Synspira touted a study today of its inhaled glycopolymer-based therapeutic with antibiotics as a potential treatment for pulmonary infection caused by the Burkholderia cepacia complex in patients with cystic fibrosis. The study was published in PLOS One. Synspira’s lead polycationic glycopolymer, SNSP113, was studied in combination with tobramycin and meropenem. These antibiotics, as well as ceftazidime, are often […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Preclinical Trials, Research & Development, Respiratory Tagged With: synspira

Study: Dangerous medication errors are on the rise

July 10, 2017 By Sarah Faulkner

Pills

According to a study published in Clinical Toxicology, researchers from Nationwide Children’s Hospital found there was a 100% increase in the rate of serious medication errors per 100,000 U.S. residents between 2000 and 2012. The team analyzed calls to Poison Control Centers across the U.S. and discovered that medication errors, those that happen outside of […]

Filed Under: Clinical Trials, Featured, Pharmaceuticals, Research & Development Tagged With: nationwidechildrenshospital

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Interim pages omitted …
  • Page 48
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS